Pharmedic

Pharmedic (PMC) is a company in Vietnam's Health Care sector, listed on HNX. The stock last traded at 124,900 VND, little changed on the session, giving a market capitalization of 1.2 trillion VND.

On valuation, PMC trades at a price-to-earnings ratio of 14.6 and a price-to-book of 4.7. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 32.3% points to strong profitability relative to the company's equity base, above the sector average of 11.5%. Trailing earnings per share stand at 8,843 VND.

Aveluro tracks 8 news items mentioning PMC, where recent coverage skews negative (50% of articles). The most recent catalyst was a dividend announcement event — "DHG leads September cash dividend wave; 50% payout, VND 654B". Aveluro's composite model rates PMC 8.3/10 (Very Bullish), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Recent developments around Pharmedic include 5 notable classified events. On Aug 31, 2026, a dividend announcement was reported: DHG will pay a 50% cash dividend (VND 5,000/share) on Sept 30, 2025, totaling nearly VND 654 billion, completing a 100% cash dividend for fiscal 2025. On Aug 22, 2026, a dividend announcement was reported: Logistics Vicem (HTV) will pay a 15% cash dividend on August 28, its highest in seven years, while Sonadezi Services (SDV) offers 25% and Pharmedic (PMC) completes its third installment at 19.64%. On Aug 17, 2026, a dividend announcement was reported: Pharmedic (PMC) will pay a third cash dividend of 1,964 VND per share on September 9, 2026, bringing total 2025 cash dividends to 43.64% (4,364 VND/share). On Jul 23, 2026, an earnings beat was reported: DHB leads Q2 2026 earnings with pretax profit of VND 779B (+1,754%), pushing 6-month profit to VND 1,063B (+1,745%). On May 15, 2026, a market event was reported: Pharmedic (PMC) has been ordered by the Drug Administration of Vietnam to recall a batch of sodium chloride 0.9% eye drops nationwide due to clarity non-compliance (level 3 violation).

The overall tone of recent coverage is positive, with 4 of 5 events carrying bullish sentiment.